A recent report by the influential Medicare Payment Advisory Commission (MedPAC) — the independent agency that advises Congress on Medicare policy — finds that Medicare pays 20 percent more per enrollee in a private Medicare Advantage (MA) plan than it would if that same individual was instead…
The Inflation Reduction Act (IRA) of 2022 includes many provisions designed to address high prescription drug prices and related out-of-pocket costs. One of the most notable changes allows Medicare to negotiate the prices of certain high-cost prescription drugs, which is expected to save Medicare…
American families have been accumulating debt at a rapid pace over the past two decades, with the debt level nearly doubling. Yet family incomes have not kept pace. As a result, the long-term retirement security of many families is at risk.
Despite the myriad of financial challenges facing patients and all Americans, many brand name drug companies have already increased the prices of their products in 2022.
There is both an opportunity and an imperative to redesign the next Scorecard. This tool has the potential to draw further attention to critical issues in LTSS exposed by the COVID-19 crisis and help states build and maintain momentum in their efforts to modernize their LTSS systems.